About Conference

Join us at the 16th International Conference on Cancer Stem Cell & Oncology Research (Cancer Stem Cells 2025), taking place on April 21-22, 2025, in the vibrant city of Amsterdam, Netherlands. This conference will focus on the theme "Precision Medicine Approaches for Cancer Stem Cell Targeting," bringing together leading experts, researchers, and practitioners in the field of oncology and cancer stem cell research.

As cancer continues to challenge medical science, innovative approaches are essential for improving patient outcomes. This conference aims to delve into cutting-edge research and advancements in precision medicine that target cancer stem cells, which play a critical role in tumorigenesis and therapy resistance.

Participants will have the opportunity to engage in thought-provoking discussions, attend keynote presentations from renowned speakers, and network with peers to foster collaboration. We encourage submissions of abstracts highlighting novel findings and methodologies related to cancer stem cells and precision oncology.

Join us in shaping the future of cancer treatment and research at Cancer Stem Cells 2025—where science meets innovation for a healthier tomorrow.

Session & Track

Track 1. CSCs and Tumor Microenvironment

Track 2. Molecular Signaling in CSCs

Track 3. Therapy Resistance and CSCs

Track 4. Epigenetics and CSC Regulation

Track 5. CSC Metabolism and Energy Pathways

Track 6. CSC Heterogeneity in Tumors

Track 7. Targeting CSC-Specific Surface Markers

Track 8. Inflammation and CSC Activation

Track 9. CSC Niche and Hypoxia

Track 10. CSC Plasticity and Tumor Progression

Track 11. CSC and Immunoediting

Track 12. CSC-Derived Exosomes and Communication

Track 13. Targeting CSC Dormancy

Track 14. Role of CSCs in Metastasis

Track 15. Drug Resistance Mechanisms in CSCs

Track 16. Natural Products and CSC Targeting

Track 17. CRISPR/Cas9 in CSC Research

Track 18. CSC Biomarkers for Early Detection

Track 19. Immunotherapy and CSCs

Track 20. CSC-Driven Angiogenesis

Track 21. Role of EMT in CSC Plasticity

Track 22. CSC-Mediated Immunosuppression

Track 23. CSC Fate Determination and Differentiation

Track 24. Nanotechnology and CSC Targeting

Track 25. CSC-Driven Resistance to Radiotherapy

Target Audience

Market Analysis Report

The global Cancer Stem Cell (CSC) and Oncology Research market is experiencing robust growth, driven by increasing cancer incidence, advancements in molecular biology, and the rising demand for targeted therapies. The market was valued at approximately USD 5 billion in 2022 and is projected to reach USD 9 billion by 2025, growing at a CAGR of around 20%.

Key factors influencing market expansion include heightened investment in R&D by pharmaceutical companies and academic institutions, the emergence of novel therapeutic modalities such as CAR-T and immune checkpoint inhibitors, and advancements in technologies like CRISPR and gene editing. The focus on precision medicine is also catalyzing growth, as researchers seek to understand the role of CSCs in tumor heterogeneity and treatment resistance.

Geographically, North America dominates the market, accounting for over 40% of the share, driven by substantial funding and a well-established healthcare infrastructure. However, the Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare expenditure, improving research capabilities, and rising patient populations.

Challenges such as high costs of research and stringent regulatory approvals may hinder market growth, but the continuous evolution of collaborative research initiatives and technological innovations presents significant opportunities. Overall, the CSC and Oncology Research market is poised for significant advancements and investment, paving the way for breakthrough therapies in cancer treatment.

Global associations and societies

• American Association for Cancer Research (AACR)

• European Society for Medical Oncology (ESMO)

• International Society for Stem Cell Research (ISSCR)

• American Society of Clinical Oncology (ASCO)

• National Cancer Institute (NCI)

• Cancer Research UK

• Society for Immunotherapy of Cancer (SITC)

• European Society of Oncology Pharmacy (ESOP)

• World Health Organization (WHO) - International Agency for Research on Cancer (IARC)

• International Society for Cell & Gene Therapy (ISCT)

Participation Benefits

1. Access to Cutting-Edge Knowledge: Gain insights from keynote presentations and sessions led by leading experts, providing attendees with the latest scientific advancements and clinical practices in cancer stem cell research.

2. Networking Opportunities: Engage in informal networking sessions, roundtable discussions, and social events, fostering connections with peers and mentors in the oncology community.

3. Presentation Opportunities: Present your own research findings through poster presentations or oral sessions, enhancing your visibility and gaining feedback from experts in the field.

4. Workshops and Tutorials: Participate in hands-on workshops and tutorials focused on the latest methodologies and technologies in cancer research, enhancing your skills and knowledge.

5. Continuing Education Credits: Earn continuing education credits that can contribute to your professional development and certification requirements.

6. Exposure to Funding Opportunities: Learn about grants, funding sources, and collaborative projects that can support your research initiatives through informational sessions.

7. Industry Insights: Gain valuable insights from industry leaders about emerging trends, challenges, and opportunities in cancer therapeutics and drug development.

8. Diverse Perspectives: Experience a rich diversity of opinions and approaches from international attendees, fostering innovative ideas and collaborative opportunities.

9. Publication Opportunities: Potential for your research to be published in associated conference proceedings or journals, increasing your work's reach and impact.

10. Community Building: Join a global community of cancer researchers and practitioners dedicated to advancing the understanding and treatment of cancer, fostering a spirit of collaboration and support.